儿童、青少年糖尿病最终版__培训课件.pptVIP

* 1415 – Danne et al. Data on File This was a multi-centre, randomised, open-label, 24-week cross-over study (two 12-week periods) safety and efficacy study. There was no washout-period between the treatments. After randomisation, during the first 2 weeks (of 12 weeks), insulin doses were titrated for dose optimisation. After 12 weeks, patients transferred to the alternative meal-time insulin. After crossover, there was a further 2-week titration period. * 1415 – Danne et al. Data on File This slide shows mean seven-point blood glucose profiles for postprandial NovoRapid? and preprandial HI. T